The 2021 guidelines include updated recommendations for treatment of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, pelvic inflammatory disease (PID) and Mycoplasma genitalium, and alternative treatment options for bacterial vaginosis (BV).